SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-18-035394
Filing Date
2018-08-03
Accepted
2018-08-03 16:21:50
Documents
78
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10q.htm 10-Q 751178
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 11605
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 11200
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 6632
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 6756
  Complete submission text file 0001140361-18-035394.txt   5459263

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rnn-20180630.xml EX-101.INS 1393847
7 XBRL TAXONOMY EXTENSION SCHEMA rnn-20180630.xsd EX-101.SCH 51815
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rnn-20180630_cal.xml EX-101.CAL 44379
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rnn-20180630_def.xml EX-101.DEF 160360
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rnn-20180630_lab.xml EX-101.LAB 363152
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rnn-20180630_pre.xml EX-101.PRE 318483
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34079 | Film No.: 18992096
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1